MGX
NASDAQ · Biotechnology
Metagenomi Therapeutics Inc
$1.19
-0.01 (-0.83%)
Open$1.18
Previous Close$1.20
Day High$1.22
Day Low$1.17
52W High$3.95
52W Low$1.13
Volume—
Avg Volume131.2K
Market Cap47.06M
P/E Ratio—
EPS$-2.30
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,471.4% upside
Current
$1.19
$1.19
Target
$30.60
$30.60
$21.05
$30.60 avg
$40.98
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 25.48M | 22.43M | 24.43M |
| Net Income | -88,801,413 | -70,359,425 | -7,358,364 |
| Profit Margin | -348.5% | -331.1% | -30.1% |
| EBITDA | -91,658,810 | -76,658,041 | -8,749,975 |
| Free Cash Flow | — | — | -5,557,893 |
| Rev Growth | +13.6% | +13.6% | -4.6% |
| Debt/Equity | — | — | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |